Can a smart device spot a hidden heart problem?

NCT ID NCT06351761

Completed Diagnosis Sponsor: Withings Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a Withings device (BeamO with ECG app) can accurately detect atrial fibrillation, a common heart rhythm problem. Over 370 adults each had a 30-second ECG with the device and a standard 12-lead ECG for comparison. The goal was to see how well the device identifies AFib versus normal rhythm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Withings SCT02 device with ECG app
What this could lead to: If successful, this could provide a convenient way for people to check for atrial fibrillation at home using a simple device.
What could go wrong: This is a completed validation study, not a treatment trial. The device may not be as accurate as a standard ECG, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Show contact details

Locations

Centre Cardiopole Trubert

Paris, France
Diverse Clinical Research

Miami, Florida, 33175, United States
FWD Clinical Research

Boca Raton, Florida, 33486, United States
Henri Mondor University Hospital

Créteil, Val de Marne, 94000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.